Cargando…
The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion
Central retinal artery occlusion (CRAO) is characterized by the sudden, painless loss of vision. Typical sonographic and optic coherence tomography (OCT) findings are a retrobulbar spot sign and prominent middle limiting membrane (p-MLM) sign. It remains uncertain whether the retrobulbar spot sign a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831102/ https://www.ncbi.nlm.nih.gov/pubmed/33477523 http://dx.doi.org/10.3390/jcm10020338 |
_version_ | 1783641566033739776 |
---|---|
author | Schnieder, Marlena Fischer-Wedi, Charlotte V. Bemme, Sebastian Kortleben, Mai-Linh Feltgen, Nicolas Liman, Jan |
author_facet | Schnieder, Marlena Fischer-Wedi, Charlotte V. Bemme, Sebastian Kortleben, Mai-Linh Feltgen, Nicolas Liman, Jan |
author_sort | Schnieder, Marlena |
collection | PubMed |
description | Central retinal artery occlusion (CRAO) is characterized by the sudden, painless loss of vision. Typical sonographic and optic coherence tomography (OCT) findings are a retrobulbar spot sign and prominent middle limiting membrane (p-MLM) sign. It remains uncertain whether the retrobulbar spot sign alone or coinciding with the appearance of p-MLM sign is a prognostic marker for visual acuity and the development of secondary retinal ischemia after CRAO. In our prospective cohort study, we included patients with a non-arteritic central artery occlusion < 4 weeks. We examined the following parameters at prespecified time points: ultrasound examination of orbital cavity, Spectral Domain-OCT examination, visual acuity test, and fundoscopy and ultra-widefield angiography to diagnose retinal vascularization. The presence of p-MLM sign in SD-OCT after CRAO was accompanied by significantly better vision during the first four weeks (2.3 (IQR 0.75) vs. 2.6 (IQR 0.33); p = 0.006). Moreover, the spot sign seems to be a prognostic factor for developing secondary retinal ischemia (8 (100%) vs. 0 (0%); p = 0.036). A retrobulbar spot sign seems to be a negative prognostic factor and is associated with secondary retinal ischemia, whereas a p-MLM sign is a somewhat positive prognostic factor for visual acuity. |
format | Online Article Text |
id | pubmed-7831102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78311022021-01-26 The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion Schnieder, Marlena Fischer-Wedi, Charlotte V. Bemme, Sebastian Kortleben, Mai-Linh Feltgen, Nicolas Liman, Jan J Clin Med Article Central retinal artery occlusion (CRAO) is characterized by the sudden, painless loss of vision. Typical sonographic and optic coherence tomography (OCT) findings are a retrobulbar spot sign and prominent middle limiting membrane (p-MLM) sign. It remains uncertain whether the retrobulbar spot sign alone or coinciding with the appearance of p-MLM sign is a prognostic marker for visual acuity and the development of secondary retinal ischemia after CRAO. In our prospective cohort study, we included patients with a non-arteritic central artery occlusion < 4 weeks. We examined the following parameters at prespecified time points: ultrasound examination of orbital cavity, Spectral Domain-OCT examination, visual acuity test, and fundoscopy and ultra-widefield angiography to diagnose retinal vascularization. The presence of p-MLM sign in SD-OCT after CRAO was accompanied by significantly better vision during the first four weeks (2.3 (IQR 0.75) vs. 2.6 (IQR 0.33); p = 0.006). Moreover, the spot sign seems to be a prognostic factor for developing secondary retinal ischemia (8 (100%) vs. 0 (0%); p = 0.036). A retrobulbar spot sign seems to be a negative prognostic factor and is associated with secondary retinal ischemia, whereas a p-MLM sign is a somewhat positive prognostic factor for visual acuity. MDPI 2021-01-18 /pmc/articles/PMC7831102/ /pubmed/33477523 http://dx.doi.org/10.3390/jcm10020338 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schnieder, Marlena Fischer-Wedi, Charlotte V. Bemme, Sebastian Kortleben, Mai-Linh Feltgen, Nicolas Liman, Jan The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion |
title | The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion |
title_full | The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion |
title_fullStr | The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion |
title_full_unstemmed | The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion |
title_short | The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion |
title_sort | retrobulbar spot sign and prominent middle limiting membrane as prognostic markers in non-arteritic retinal artery occlusion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831102/ https://www.ncbi.nlm.nih.gov/pubmed/33477523 http://dx.doi.org/10.3390/jcm10020338 |
work_keys_str_mv | AT schniedermarlena theretrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT fischerwedicharlottev theretrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT bemmesebastian theretrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT kortlebenmailinh theretrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT feltgennicolas theretrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT limanjan theretrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT schniedermarlena retrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT fischerwedicharlottev retrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT bemmesebastian retrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT kortlebenmailinh retrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT feltgennicolas retrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion AT limanjan retrobulbarspotsignandprominentmiddlelimitingmembraneasprognosticmarkersinnonarteriticretinalarteryocclusion |